Felice, Carla
 Distribuzione geografica
Continente #
NA - Nord America 1.447
EU - Europa 1.223
AS - Asia 870
SA - Sud America 161
AF - Africa 27
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.730
Nazione #
US - Stati Uniti d'America 1.408
DE - Germania 551
SG - Singapore 389
CN - Cina 227
SE - Svezia 144
BR - Brasile 124
FR - Francia 107
UA - Ucraina 95
IT - Italia 89
GB - Regno Unito 72
VN - Vietnam 70
IN - India 46
FI - Finlandia 39
IE - Irlanda 36
ID - Indonesia 31
CA - Canada 27
RU - Federazione Russa 24
BD - Bangladesh 20
JP - Giappone 19
TR - Turchia 17
AR - Argentina 16
PL - Polonia 14
BE - Belgio 12
ES - Italia 9
NL - Olanda 9
EC - Ecuador 7
HK - Hong Kong 6
IR - Iran 6
MX - Messico 6
ZA - Sudafrica 6
AT - Austria 5
JM - Giamaica 5
MA - Marocco 5
CI - Costa d'Avorio 4
IQ - Iraq 4
KR - Corea 4
PH - Filippine 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CO - Colombia 3
PK - Pakistan 3
SA - Arabia Saudita 3
UY - Uruguay 3
BH - Bahrain 2
CH - Svizzera 2
EG - Egitto 2
GR - Grecia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MM - Myanmar 1
MY - Malesia 1
QA - Qatar 1
SC - Seychelles 1
TW - Taiwan 1
Totale 3.730
Città #
Chandler 227
Singapore 217
San Jose 142
Ashburn 138
Jacksonville 80
San Mateo 50
Beijing 49
New York 48
Dearborn 47
Ann Arbor 38
Nürnberg 37
Munich 36
Dublin 34
Cattolica 30
Nanjing 28
Jakarta 26
Lauterbourg 26
Los Angeles 26
Wilmington 25
Milan 20
Bremen 17
Hefei 17
Ho Chi Minh City 17
Boston 16
São Paulo 16
Dallas 15
Frankfurt am Main 15
Houston 15
Tokyo 15
Lawrence 14
Brussels 12
Lancaster 11
Buffalo 10
Hanoi 10
Helsinki 10
Izmir 10
Moscow 10
Toronto 10
Turku 10
Warsaw 10
Princeton 9
Seattle 9
Düsseldorf 8
Leawood 8
London 8
Nanchang 8
Rome 8
Detroit 7
Jiaxing 7
Paris 7
Redwood City 7
Haiphong 6
Hong Kong 6
Marseille 6
Montreal 6
Mountain View 6
Shanghai 6
Shenyang 6
Stockholm 6
Boardman 5
Brooklyn 5
Changsha 5
Denver 5
Hebei 5
San Francisco 5
The Dalles 5
Woodbridge 5
Abidjan 4
Andover 4
Ardabil 4
Augusta 4
Belo Horizonte 4
Calgary 4
Chennai 4
Curitiba 4
Da Nang 4
Dhaka 4
Fairfield 4
Guangzhou 4
Johannesburg 4
Mumbai 4
Orem 4
Philadelphia 4
Phoenix 4
Redmond 4
Seoul 4
Tianjin 4
Vienna 4
Amsterdam 3
Brasília 3
Casablanca 3
Costa Mesa 3
Duque de Caxias 3
Edinburgh 3
Hangzhou 3
Jinan 3
Kent 3
Kingston 3
Kunming 3
Manaus 3
Totale 1.878
Nome #
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 223
FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents 212
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 198
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. 191
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 190
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study 190
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants. 189
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 174
Ileal Crohn's disease: CEUS determination of activity 172
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents 171
Use of infliximab in particular clinical settings: management based on current evidence. 156
Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association 154
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 139
Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis 132
Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases 130
Management of perianal fistulas in Crohn's disease: an up-to-date review 127
What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients? 124
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 113
AID in aging and autoimmune diseases 112
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 106
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 104
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 101
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 97
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study 89
Acute cytomegalovirus infection as a possible trigger for pulmonary thromboembolism in a patient with steroid-refractory ulcerative colitis. 86
Biological therapies for inflammatory bowel disease: controversies and future options 76
Totale 3.756
Categoria #
all - tutte 14.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.008


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/2022237 27 17 4 39 4 3 3 47 7 4 30 52
2022/2023528 71 73 33 103 33 63 17 40 68 2 15 10
2023/2024244 10 50 6 20 3 50 3 33 10 12 24 23
2024/2025457 5 18 49 11 61 15 18 28 52 49 82 69
2025/20261.147 188 37 63 142 200 58 213 49 65 72 31 29
Totale 3.756